Author response for "Consolidation with 90 Yttrium‐ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma"
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI